Evaluation of the Interest of a Postural and Functional Analysis for the Follow-up of the Adapted Motor Activity of Patients Treated for Breast Cancer
NCT ID: NCT05677022
Last Updated: 2024-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2023-02-01
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participant population/health conditions: patients with newly operated breast cancer who are candidates for an adapted physical activity program
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adapted Physical Activity Effect and Fatigue in Patients With Breast Cancer
NCT01322412
Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without Radiation
NCT01157767
Strength After Breast Cancer
NCT06052488
Multidisciplinary Rehabilitation Programme for Breast Cancer
NCT05306808
Mechanical Stimulation on Pain Level and Functional Discomfort After Breast Cancer Surgery
NCT04202640
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All included patients will be followed for a period of 15 months. Participating physicians will have the opportunity to recruit their patients during the 24 months following the study's initiation. The study will be completed once the last included patient has a final evaluation. The total duration of the study is 39 months (24 months of recruitment and 15 months of follow-up).
Each patient will be assessed four times: at inclusion before initiation of cancer treatment, and at M3, M9 and M15. At each patient visit with the investigating physician, an assessment will be completed on the electronic CRF by the physician or by the site CRA under the responsibility of the investigating physician.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adapted motor activity
Adapted motor activity
15-month adapted motor activity program based on a postural and functional analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adapted motor activity
15-month adapted motor activity program based on a postural and functional analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with non-metastatic breast cancer,
* Cancer to be treated by surgery with or without adjuvant treatment (radiotherapy and/or chemotherapy).
Exclusion Criteria
* Mental deficiency or any other reason that could hinder the understanding or the strict application of the protocol,
* Patient not affiliated to the French social security system,
* Patient under legal protection, guardianship or curatorship,
* Patient already included in another therapeutic study protocol aimed at evaluating the benefits of adapted physical activity.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GCS Ramsay Santé pour l'Enseignement et la Recherche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clairval Hospital Center
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A03091-40
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.